Engraftment status
| . | Primary disease . | All diseases, n (%) . | |
|---|---|---|---|
| HLH, n (%) . | Other PID, n (%) . | ||
| Total (n) | 34 | 12 | 46 |
| Sustained engraftment | |||
| Sustained donor chimerism >5%, alive at 1 y, no intervention | 14 (41) | 4 (33) | 18 (39) |
| Received DLI and/or second HCT | |||
| Donor chimerism >5% after intervention | 9 (26) | 1 (8) | 10 (22) |
| Donor chimerism ≤5% after intervention | 3 (9) | 2 (17) | 5 (11) |
| Primary graft failure | |||
| Donor chimerism remained ≤5% after initial HCT | 1 (3) | 1 (8) | 2 (4) |
| Secondary graft failure | |||
| Donor chimerism ≤5% without intervention | 1 (3) | 1 (8) | 2 (4) |
| Not evaluable for sustained engraftment | |||
| Donor chimerism 53% at day 28, died before day 42 | 1 (3) | 0 (0) | 1 (2) |
| Sustained donor chimerism >5%, dead before 1 y | 5 (15) | 3 (25) | 8 (17) |
| . | Primary disease . | All diseases, n (%) . | |
|---|---|---|---|
| HLH, n (%) . | Other PID, n (%) . | ||
| Total (n) | 34 | 12 | 46 |
| Sustained engraftment | |||
| Sustained donor chimerism >5%, alive at 1 y, no intervention | 14 (41) | 4 (33) | 18 (39) |
| Received DLI and/or second HCT | |||
| Donor chimerism >5% after intervention | 9 (26) | 1 (8) | 10 (22) |
| Donor chimerism ≤5% after intervention | 3 (9) | 2 (17) | 5 (11) |
| Primary graft failure | |||
| Donor chimerism remained ≤5% after initial HCT | 1 (3) | 1 (8) | 2 (4) |
| Secondary graft failure | |||
| Donor chimerism ≤5% without intervention | 1 (3) | 1 (8) | 2 (4) |
| Not evaluable for sustained engraftment | |||
| Donor chimerism 53% at day 28, died before day 42 | 1 (3) | 0 (0) | 1 (2) |
| Sustained donor chimerism >5%, dead before 1 y | 5 (15) | 3 (25) | 8 (17) |